18 Members•4,119 Posts

Health

BioVie to highlight neuro and liver disease programs in June 2 investor webinar

May 27, 2026

Angela Harmantas

AtaiBeckley to participate in multiple June investor conferences

May 27, 2026

Emily Jarvie

Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials

May 27, 2026

Emily Jarvie

ImmuPharma focused on securing P140 licensing deal in 2026

May 27, 2026

Ian Lyall

Recce signs major MENA 10-year licensing deal

May 27, 2026

Kerry Stevenson

BioVie completes enrollment in Long COVID trial as need for treatments grows

May 26, 2026

Steve Darling

Hims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofA

May 26, 2026

Angela Harmantas

Leading banks back Oxford Nanopore after London Calling showcases maturing platform

May 26, 2026

Ian Lyall

Percheron Therapeutics secures proposed WHO drug name for HMBD-002 cancer therapy

May 26, 2026

Lisa Uhlman

Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms

May 26, 2026

Emily Jarvie

Imugene strengthens board with biotech and pharma appointments

May 26, 2026

Jonathan Jackson

Cavendish says FDA alignment de-risks Poolbeg Pharma's lead cancer therapy programme for partners

May 26, 2026

Ian Lyall

BioVie completes enrollment in Phase 2 Long COVID trial

May 26, 2026

Angela Harmantas

Poolbeg Pharma gets positive FDA feedback for development pathway of lead cancer therapy asset

May 26, 2026

Ian Lyall

Eli Lilly weight loss drug data supports long-term obesity market position, says UBS

May 25, 2026

Emily Jarvie

Inside Biotech: Lilly’s retatrutide raises the bar again in the obesity drug race

May 25, 2026

Lisa Uhlman

Nutritional Growth Solutions to acquire Sprout Organic in plant-based infant formula deal

May 25, 2026

Jonathan Jackson

Bram Goorden discusses IXICO growth plans - ICYMI

May 24, 2026

Ian Lyall

OKYO Pharma expands scientific advisory board with cornea expert - ICYMI

May 23, 2026

Emily Jarvie

Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI

May 22, 2026

Angela Harmantas

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy